文献速递神经肿瘤

蝶眶脑膜瘤:复发预测因素与手术治疗新策略

Spheno-orbital meningiomas: predictors of recurrence and novel strategies for surgical management.
PubMed 文献 · J Neurosurg · 2025-05-02

该回顾性单中心研究纳入2011至2021年接受手术的89例蝶眶脑膜瘤患者,分析骨性肿瘤部分与软组织肿瘤部分切除程度与复发的关系。中位随访78个月,软组织肿瘤部分残留体积与复发显著相关,而骨性肿瘤部分体积与复发无显著相关。作者认为安全最大程度切除软组织肿瘤部分可能有助于降低复发率。

要点

  • 术后软组织肿瘤部分体积与复发显著相关(p<0.001),骨性肿瘤部分体积与复发无显著相关(p>0.05)。
  • 术后软组织肿瘤部分体积大于3.7 mm3者复发风险调整OR为1.342(p<0.001),无进展生存期更短(p=0.049)。
  • 首次手术后复发率为22.5%,其中20%接受二次手术、80%接受立体定向放射外科治疗。

核心结论

  • 作者认为安全最大程度切除软组织肿瘤部分可能有助于降低蝶眶脑膜瘤复发率,而这一策略似乎不适用于骨性肿瘤部分。
  • 作者认为蝶眶脑膜瘤的手术策略应量身定制,优先最大程度切除软组织肿瘤部分,骨性肿瘤部分的切除应基于眶直接受压或静脉淤血所致神经功能缺损来定制。

研究设计与样本

  • 回顾性单中心连续病例系列,纳入2011至2021年接受手术治疗的蝶眶脑膜瘤患者89例,女男性别比为8.9:1。
  • 从机构病历收集人口学与临床数据,分析术前及术后头颅CT与MRI,按影像学特征识别并分割软组织肿瘤部分与骨性肿瘤部分。
  • 采用Kaplan-Meier法评估无进展生存期,考虑复发时治疗方案(立体定向放射外科 versus 手术),并应用约登指数确定最佳残留软组织肿瘤部分体积截断值。

主要发现

  • 平均随访78个月,60%患者有使用避孕药超过10年的病史。
  • 术后骨性肿瘤部分体积与复发无显著相关(p>0.05),而软组织肿瘤部分与复发显著相关(p<0.001)。
  • 首次手术后复发率为22.5%,其中20%接受二次手术、80%接受立体定向放射外科治疗;仅3.4%患者在整个随访期间需要三次治疗。
  • 术后软组织肿瘤部分体积大于3.7 mm3者复发风险调整OR为1.342(p<0.001),无进展生存期更短(p=0.049)。

关键数值与推荐

  • 术后软组织肿瘤部分体积大于3.7 mm3者复发风险调整OR为1.342(p<0.001),无进展生存期更短(p=0.049)。
  • 术后骨性肿瘤部分体积与复发无显著相关(p>0.05);术后软组织肿瘤部分体积与复发显著相关(p<0.001)。
  • 首次手术后复发率为22.5%,复发患者中20%接受二次手术、80%接受立体定向放射外科治疗。

临床怎么用

  • 作者认为蝶眶脑膜瘤手术应量身定制,优先最大程度安全切除软组织肿瘤部分。
  • 作者认为骨性肿瘤部分的切除应基于眶直接受压或静脉淤血所致神经功能缺损来定制。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spheno-orbital meningiomas (SOMs) represent approximately 2%-9% of tumors affecting the sphenoid wings. The main challenge in treating these meningiomas is achieving gross-total resection (GTR) due to the hyperostosis, which is pathognomonic. This study explored potential correlations between the recurrence rate of SOM and the extent of resection (EOR) of both the bony tumor portion (BTP) and soft tumor portion (STP). Additionally, it analyzed the progression-free survival (PFS) of SOM patients in relation to the EOR, adjuvant treatments, and other recognized risk factors, including demographic, clinical, and radiological characteristics. METHODS: This retrospective study included a consecutive series of patients surgically treated for SOM at a single institution between 2011 and 2021. Demographic and clinical data were gathered from institutional medical records. Preoperative and postoperative brain CT and MRI scans were analyzed, with the STP and BTP identified and segmented based on their radiological characteristics. PFS was assessed using the Kaplan-Meier method, considering treatment options at recurrence (stereotactic radiosurgery [SRS] versus surgery) and applying the Youden index to determine the optimal residual STP volume cutoff. RESULTS: The study cohort included 89 patients diagnosed with SOM, with a female-to-male ratio of 8.9:1. The average follow-up period was 78 months. Sixty percent of the patients had a history of contraceptive use for more than 10 years. While no significant correlation was found between postoperative BTP volume and recurrence (p > 0.05), a significant correlation was observed for the STP (p < 0.001). The recurrence rate after the initial surgery was 22.5%, with 20% of those patients undergoing a second surgery and 80% treated with SRS. Only 3.4% of patients required three treatments throughout the follow-up. Patients with a postoperative STP volume greater than 3.7 mm3 had an adjusted OR of 1.342 for recurrence risk (p < 0.001) and shorter progression-free survival (p = 0.049). CONCLUSIONS: This study suggests that achieving a safe maximal resection of the STP might help lower the recurrence rate of SOM, whereas this does not appear to apply to the BTP. Overall, the surgical approach for SOM should be tailored to prioritize maximal resection of the STP. Conversely, removal of the BTP should be tailored based on neurological deficits caused by direct compression of the orbit or venous congestion.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Porto E, Carone G, Fiore G, et al. Spheno-orbital meningiomas: predictors of recurrence and novel strategies for surgical management. J Neurosurg. 2025. PMID: 40315600. doi:10.3171/2025.1.JNS241846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。